36th Annual Roth Conference | Accuray Incorporated

Skip to main navigation

Home
Governance
News & Events
SEC Filings
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Resources

Event Details

Home / Investor Relations /

36th Annual Roth Conference

Mar 18, 2024 at 12:30 PM PDT

Print Page

RSS

Email Alerts

Tear Sheet

Investor Contacts

Investor Contacts

Connect with us on social media.

Linkedin Facebook Twitter Youtube

1240 Deming Way
Madison, WI 53717-1954
Phone: +1.608.824.2800
Fax: +1.608.824.2996

CyberKnife®
Radixact®
TomoTherapy®
Accuray Precision® Treatment Planning
iDMS® Data Management

Careers
Services
Patients
Investors
Contact Us

Conflict Minerals Policy Statement
Privacy Policy
Terms of Use
Ethicspoint Hotline

© 2007 - 2020 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi•Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.

Safety Statement for Radiation Treatment:
Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.